| Preface to the Second Edition | |
| Preface to the First Edition | |
| Contributors | |
| Introduction | |
| Transfusion Into the Next Millennium | p. 1 |
| Red Cell Production | p. 13 |
| Hemoglobin Synthesis, Structure and Oxygen Transport | p. 23 |
| Red Cell Metabolism | p. 37 |
| Red Cell Radiolabeling and Kinetics | p. 43 |
| Liquid Preservation of Red Cells | p. 51 |
| Frozen Red Blood Cells | p. 61 |
| Human Blood Group Antigens and Antibodies | p. 67 |
| Erythrocytosis | p. 89 |
| Anemia and Red Cell Transfusion | p. 95 |
| Autoimmune Hemolytic Anemia | p. 101 |
| Paroxysmal Nocturnal Hemoglobinuria | p. 121 |
| Hemolytic Disease of the Newborn: Treatment and Prevention | p. 127 |
| Management of Congenital Hemolytic Anemias | p. 141 |
| Transfusion in the Hypoproliferative Anemias | p. 161 |
| Red Cell Transfusions in Pediatrics | p. 167 |
| Pharmacological Interventions as Alternatives to Blood Transfusion | p. 177 |
| Perflurocarbons | p. 189 |
| Hemoglobin Solution as an Acellular Oxygen Carrier | p. 197 |
| Megakaryocytopoiesis and Platelet Kinetics | p. 207 |
| Role of Platelets in Hemostasis | p. 221 |
| Platelet Immunology and Alloimmunization | p. 231 |
| Preparation and Storage of Platelet Concentrates | p. 245 |
| Thrombocytopenia and Platelet Transfusions | p. 257 |
| Platelet Transfusion in Patients Receiving Chemotherapy | p. 263 |
| Immune Thrombocytopenia and Its Management | p. 275 |
| Alloimmune Thrombocytopenias | p. 297 |
| Platelet Consumption and Dysfunction | p. 309 |
| Neutrophil and Lymphocyte Kinetics | p. 315 |
| Granulocyte Transfusions | p. 321 |
| Therapeutic Mononuclear Cell Transfusion: Adoptive Immunotherapy and Gene Therapy | p. 329 |
| Hematopoietic Growth Factors | p. 345 |
| Leukoreduced Blood Components: Laboratory and Clinical Aspects | p. 353 |
| Leukocyte Inactivation by Blood Irradiation | p. 375 |
| Composition of Plasma | p. 383 |
| Coagulation Mechanism | p. 393 |
| Preparation of Plasma Derivatives | p. 403 |
| Transfusion of Plasma | p. 415 |
| Congenital Coagulopathies and Their Management | p. 423 |
| Bleeding from Acquired Coagulation Disorders and Antithrombotic Therapy | p. 435 |
| Management of Disseminated Intravascular Coagulation | p. 443 |
| Immunoglobulins in Clinical Medicine | p. 453 |
| The Processing and Preservation of Hematopoietic Progenitor Cells | p. 465 |
| Allogeneic Bone Marrow Transplantation: General Principles and Current Practice | p. 475 |
| Allogenic Bone Marrow Transplantation: Current Problems and Possible Solutions | p. 493 |
| High-dose Therapy with Autologous Hematopoietic Stem Cell Transplantation for the Treatment of Malignant Disease | p. 509 |
| Transfusion Support in Bone Marrow Transplantation | p. 521 |
| Apheresis: Principles and Practices | p. 537 |
| Plateletpheresis | p. 547 |
| Leukopheresis and Stem Cell Harvest | p. 551 |
| Plasma Exchange in Neurological, Hematological, and Other Autoimmune Diseases | p. 559 |
| Plasma Exchange in the Dysproteinemias | p. 569 |
| Plasma Exchange in Thrombotic Microangiopathies | p. 577 |
| The Physiologic Basis of Transfusion | p. 583 |
| Preoperative Autologous Blood Donation | p. 593 |
| Preoperative Hemodilution | p. 601 |
| Intraoperative Autotransfusion | p. 607 |
| Metabolic Effects of Massive Transfusion | p. 615 |
| Volume Replacement in the Surgical Patient | p. 627 |
| Solid-organ Transplantation | p. 635 |
| Preoperative Assessment of Hemostasis | p. 641 |
| Diagnosis and Management of Intraoperative and Postoperative Hemostatic Defects | p. 649 |
| Surgery in the Patient With Congenital Coagulopathies | p. 661 |
| The Potential Role of Human Recombinant Erythropoietin in the Surgical Patient | p. 667 |
| Transfusion-transmitted Hepatitis A, B, and D | p. 675 |
| Transfusion-transmitted Non-A, Non-B and Hepatitis C Virus Infections | p. 687 |
| Transfusion-associated AIDS | p. 699 |
| Transfusion-transmitted HTLV-I and HTLV-II | p. 709 |
| Transfusion-transmitted Cytomegalovirus and Epstein-Barr Virus Diseases | p. 717 |
| Transmission of Parasitic Infections by Blood Transfusion | p. 733 |
| Bacterial Transmission by Transfusion | p. 739 |
| Hemolytic Transfusion Reactions | p. 747 |
| Plasma Anaphylaxis and Immediate Type Reactions | p. 765 |
| Febrile and Nonimmune Transfusion Reactions | p. 773 |
| Transfusion-associated Graft-versus-Host Disease | p. 785 |
| Transfusion-associated Immunosuppression | p. 803 |
| HLA: The Molecular Age | p. 813 |
| Tissue and Organ Preservation and Transplantation | p. 825 |
| Organ and Tissue Procurement | p. 839 |
| Applications of Genetic Marker Typing in Disputed Parentage Cases | p. 849 |
| Blood and Plasma Services in the United States | p. 863 |
| Recruitment and Evaluation of Blood and Plasma Donors | p. 871 |
| Current Good Manufacturing Practices | p. 883 |
| The Hospital Transfusion Service: Management and Administration | p. 893 |
| Quality Assessment and Improvement of Transfusion Practices | p. 907 |
| International Aspects of Blood Services | p. 917 |
| Medicolegal Aspects of Blood Transfusion | p. 925 |
| Index | p. 935 |
| Table of Contents provided by Blackwell. All Rights Reserved. |